Tip on policy shift jolted health shares

Wall Street Journal

A private message alerting investors on the CMS' flip on Medicare Advantage rates is throwing a spotlight on the controversial "political intelligence" industry.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
UnitedHealthcare CEO’s killing unleashes rage against insurers
2
Kaiser-backed Risant Health completes Cone Health acquisition
3
What to expect in the primary care market in 2030
4
UnitedHealthcare CEO Brian Thompson's killing shocks industry
5
Police: UnitedHealthcare CEO shooting a 'brazen, targeted attack'